SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-237624
Filing Date
2023-09-19
Accepted
2023-09-19 16:06:00
Documents
12
Period of Report
2023-09-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d554050d8k.htm   iXBRL 8-K 27253
  Complete submission text file 0001193125-23-237624.txt   145151

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA me-20230915.xsd EX-101.SCH 2844
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE me-20230915_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE me-20230915_pre.xml EX-101.PRE 10810
6 EXTRACTED XBRL INSTANCE DOCUMENT d554050d8k_htm.xml XML 3247
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

IRS No.: 871240344 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-39587 | Film No.: 231263738
SIC: 2834 Pharmaceutical Preparations